Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma
ConditionRenal Cell Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorAssiut University
About this trial
1. Study the expression of CD44 in various histopathological types of RCC. 2. Study the association between CD44 expression and other clinicopathological parameters 3. study the impact of CD44 expressions in tumor and patients' survival
Eligibility criteria
Qualifiers
patient must be more than 18 years
Patients with complete pathological data
Disqualifiers
The presence of any other organ malignancies
Patients who lost follow-up after nephrectomy less than 3-year,
Patients with incomplete pathological data
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov